L-Ascorbic Acid Stimulates Expression of Smooth Muscle-Specific Markers in Smooth Muscle Cells both in Vitro and in Vivo

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 6, 2003, Pages 745-751

  Arakawa, Emi ^a,b   Hasegawa, Kazuhide ^a   Irie, Junko ^b   Ide, Shinichi ^b   Ushiki, Junko ^b   Yamaguchi, Kazuo ^b   Oda, Shoji ^b   Matsuda, Yuzuru ^a  

^a Vessel Research Laboratory Co Ltd   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Ascorbic acid; Calponin 1; Differentiation; Smooth muscle specific myosin heavy chain 1; Vascular smooth muscle cell

Indexed keywords

5,6 ISOPROPYRIDENE ASCORBIC ACID; ASCORBIC ACID; ASCORBIC ACID 2 PHOSPHATE; ASCORBIC ACID DERIVATIVE; BIOCHEMICAL MARKER; CALPONIN; GLUCONO GAMMA LACTONE; ISOASCORBIC ACID; MYOSIN HEAVY CHAIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY INJURY; CELL CULTURE; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; CALCIUM-BINDING PROTEINS; CAROTID ARTERIES; CELLS, CULTURED; MALE; MICROFILAMENT PROTEINS; MUSCLE, SMOOTH, VASCULAR; MYOSIN HEAVY CHAINS; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

EID: 0344154555     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200312000-00008     Document Type: Article

References (33)

1. Goldfried SL, Deckelbaum LI. Natural antioxidants and restenosis after percutaneous transluminal coronary angioplasty. Am Heart J. 1995;129: 203-210.
2. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness. The ARIC study. Circulation. 1995;92: 2142-2150.
3. Frei B, England L, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci USA. 1989;86:6377-6381.
4. Jialal I, Grundy SM. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification. J Clin Invest. 1991;87:597-601.
5. Harats D, Ben-Naim M, Dabach Y, et al. Effect of vitamin C and E supplementation on susceptibility of plasma lipoproteins to peroxidation induced by acute smoking. Atherosclerosis. 1990;85:47-54.
6. Willis GC. The reversibility of atherosclerosis. Can M A J. 1957;77: 106-109.
7. Willis GC. An experimental study of the intimal ground substance in atherosclerosis. Can M A J. 1953;69:17-22.
8. Ginter E, Bobek P, Jurcovicova M. Role of L-ascorbic acid in lipid metabolism. In: Seib PA, Tolbert BM, eds. Ascorbic Acid: Chemistry, Metabolism and Uses. American Chemical Society: Washington D.C.; 1982: 381-395.
9. Jacques PF, Sulsky SI, Perrone G, et al. Ascorbic acid and plasma lipids. Epidemiology. 1994;5:19-26.
10. Church JP, Judd JT, Young CW, et al. Relationships among dietary constituents and specific serum clinical components of subjects eating self-selected diets. Am J Clin Nutr. 1984;40 (6 Suppl):1338-1344.
11. Ivanov VO, Ivanova SV, Niedzwiecki A. Ascorbate affects proliferation of guinea-pig vascular smooth muscle cells by direct and extracellular matrix-mediated effects. J Mol Cell Cardiol. 1997;29:3293-3303.
12. Siow RC, Richards JP, Pedley KC, et al. Vitamin C protects human vascular smooth muscle cells against apoptosis induced by moderately oxidized LDL containing high levels of lipid hydroperoxides. Arterioscler Thromb Vasc Biol. 1999;19:2387-2394.
13. Arakawa E, Hasegawa K, Yanai N, et al. A mouse bone marrow stromal cell line, TBR-B, shows inducible expression of smooth muscle-specific genes. FEBS Lett. 2000;48:193-196.
14. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191-207.
15. Schwartz RS, Holmes DR Jr, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol. 1992; 20:1284-1293.
16. Campbell JH, Kocher O, Skalli O, et al. Cytodifferentiation and expression of alpha-smooth muscle action mRNA and protein during primary culture of aortic smooth muscle cells. Correlation with cell density and proliferative state. Arteriosclerosis. 1989;9:633-643.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-685.
18. Hasegawa K, Arakawa E, Oda S, et al. Novel smooth muscle cell lines from transgenic mice harboring temperature-sensitive SV40 large T-antigen gene. Temperature-dependent expression of smooth muscle myosin heavy chain-1 and calponin genes. J Mol Cell Cardiol. 1997;29: 2177-2186.
19. Ohkubo A, Takaku F. cDNA cloning of a myosin heavy chain isoform in embryonic smooth muscle and its expression during vascular development and in arteriosclerosis. J Biol Chem. 1991;266:3768-3773.
20. Shanahan CM, Weissberg PL, Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cell. Circ Res. 1993;73:193-204.
21. Weissberg PL, Cary NR, Shanahan CM. Gene expression and vascular smooth muscle cell phenotype. Blood Press. 1995;4(Suppl 2):68-73.
22. Taylor SM, Jones PA. Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell. 1979;17:771-779.
23. Rosselot G, Reginato AM, Leach RM. Development of a serum-free system to study the effect of growth hormone and insulinlike growth factor-1 on cultured postembryonic growth plate chondrocytes. In Vitro Cell Dev Biol. 1992;28A:235-244.
24. Nandan D, Clarke EP, Ball EH, et al. Ethyl-3,4-dihydroxybenzoate inhibits myoblast differentiation: evidence for an essential role of collagen. J Cell Biol. 1990;110:1673-1679.
25. Mitsumoto Y, Liu Z, Klip A. A long-lasting vitamin C derivative, ascorbic acid 2-phosphate, increases myogenin gene expression and promotes differentiation in L6 muscle cells. Biochem Biophys Res Commun. 1994;199: 394-402.
26. Franceschi RT, Iyer BS. Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res. 1992;7:235-246.
27. Torii Y, Hitomi K, Tsukagoshi N. Synergistic effect of BMP-2 and ascorbate on the phenotypic expression of osteoblastic MC3T3-E1 cells. Mol Cell Biochem. 1996;165:25-29.
28. Shanahan CM, Cary NR, Metcalfe JC, et al. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest. 1994;93:2393-2402.
29. Aikawa M, Sivam PN, Kuro-o M, et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res. 1993;73:1000-1012.
30. Mano T, Luo Z, Malendowicz SL, et al. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res. 1999;84: 647-654.
31. Aikawa M, Rabkin E, Voglic SJ, et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res. 1998;83:1015-1026.
32. Fingerle J, Muller RM, Kuhn H, et al. Mechanism of inhibition of neo-intimal formation by the angiotensin-converting enzyme inhibitor cilazapril. A study in balloon catheter-injured rat carotid arteries. Arterioscler Thromb Vasc Biol. 1995;15:1945-1950.
33. Tomoda H, Yoshitake M, Morimoto K, et al. Possible prevention of post-angioplasty restenosis by ascorbic acid. Am J Cardiol. 1996;78: 1284-1286.